Abstract
The reemergence of tuberculosis, including the impact of HIV infection and multidrug-resistant tuberculosis, have renewed interest in the bacille Calmette-Guérin (BCG) vaccine. During the past 7 decades, numerous studies have shown variable efficacy of BCG vaccination, ranging from 0% to 80%. The BCG vaccine is more likely to prevent disseminated forms of tuberculosis in children than pulmonary tuberculosis in adolescents or adults. Bacille Calmette-Guérin vaccination is recommended in asymptomatic children with or at risk for HIV infection, but it rarely may cause disseminated BCG infection and should not be used in persons with symptomatic HIV infection or AIDS. In healthcare workers with exposure to Mycobacterium tuberculosis, including multidrug-resistant tuberculosis, BCG vaccination generally is not recommended. Revaccination with BCG does not confer more benefit than initial vaccination, and repeat vaccinations should be discontinued. With recent advances in technology and a better understanding of the immunopathogenesis of tuberculosis, efforts to develop a more potent and specific vaccine need to be pursued. If a more effective vaccine against tuberculosis is developed, vaccination can be expected to have an additional...Continue Reading
References
Dec 1, 1992·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·R L SepulvedaR U Sorensen
Feb 1, 1991·AIDS·S Lallemant-Le CoeurB Larouze
Nov 1, 1990·The Journal of Infectious Diseases·C ArmbrusterG Jaksch
Aug 1, 1988·The American Review of Respiratory Disease·G W Comstock
Jun 1, 1983·Tubercle·J M GrangeM D Yates
Aug 1, 1994·Controlled Clinical Trials·G W Comstock
Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·R L SepulvedaR U Sorensen
Feb 1, 1993·AIDS·A C Weltman, D N Rose
Oct 1, 1950·Annals of Internal Medicine·H A DICKIE
Citations
Sep 25, 2003·Vaccine·Peter SanderM Joseph Colston
Dec 26, 2001·Veterinary Microbiology·L A L CornerR S Morris
Apr 8, 2011·Journal of Biomolecular Structure & Dynamics·Teodorico C RamalhoElaine F F da Cunha
Feb 24, 2001·AIDS·R D WaddellUNKNOWN Dartmouth/UCLMS/UNZA Collaborative Study Group
Jan 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wing Wai Yew, Chi Chiu Leung
Dec 13, 2006·Pediatric Dermatology·Li-Hsin HuangChin-Yuan Tzen
Aug 30, 2008·Infection and Immunity·Michael V TulliusMarcus A Horwitz
May 12, 2001·Infection and Immunity·P SanderE C Böttger
Feb 24, 2004·Infection and Immunity·L Holten-AndersenP Andersen
Oct 22, 2005·Infection and Immunity·Adel M Talaat, Katherine Stemke-Hale
Sep 8, 2006·Journal of Immune Based Therapies and Vaccines·Renata Monteiro-MaiaLuiz R R Castello-Branco
Dec 13, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·M DaraUNKNOWN International Union Against Tuberculosis and Lung Disease
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Adel M TalaatStephen Albert Johnston
Oct 3, 1999·Lancet·F Shann, M C Steinhoff
May 1, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mahnaz Sadeghi-Shabestari, Nima Rezaei
Feb 23, 2000·Virology·N J LeungJ V Torres
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L K ArchibaldW R Jarvis
May 27, 2005·Vaccine·Yasir A W SkeikyAntonio Campos-Neto
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·D J Kusner, J Adams